Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:IQV
IQVIA Holdings
|
229.20 | 18.27% | 35.28% | 41,760.24 | 0% | 12.94% |
|
NasdaqGS:IDXX
IDEXX Laboratories
|
500.82 | 6.42% | 20.9% | 41,361.39 | 0% | 18.75% |
|
NasdaqGS:ICLR
ICON Public
|
315.04 | 8.61% | 23.77% | 26,048.71 | 0% | 16% |
|
ENXTBR:ARGX
argenx
|
348.90 | 0% | 0% | 20,719.96 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2003.00 | 67.93% | 128.66% | 129,376.32 | 0% | 22.71% |
|
XTRA:SRT3
Sartorius
|
281.80 | 23.29% | 52.53% | 17,474.21 | 0.27% | 14.01% |
|
SWX:SGSN
SGS
|
82.38 | 868.01% | 946.92% | 15,592.56 | 3.88% | -1.74% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
206.15 | -9.26% | 0.46% | 17,377.13 | 1.43% | 4.24% |
|
NYSE:DGX
Quest Diagnostics
|
138.16 | -6.76% | 2.3% | 15,348.41 | 2.2% | 6.66% |
|
ENXTPA:BVI
Bureau Veritas
|
28.40 | 4.59% | 15.11% | 12,884.95 | 2.94% | 5.76% |
|
NYSE:CRL
Charles River Laboratories International
|
230.09 | 15.62% | 31.45% | 11,815.07 | 0% | 12.09% |
|
ENXTPA:ERF
Eurofins Scientific
|
57.28 | 14% | 29.25% | 11,046.73 | 0.87% | 7.46% |
|
NasdaqGS:MEDP
Medpace Holdings
|
399.20 | -18.97% | -3.47% | 12,340.6 | 0% | 25.99% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
50.35 | 18.28% | 30.99% | 10,363.08 | 2.34% | 10.99% |
|
LSE:ITRK
Intertek Group
|
50.55 | 5,998.22% | 6,510.77% | 8,150.85 | 2.2% | 2.41% |
|
NYSE:CTLT
Catalent
|
55.98 | -57.4% | -7.04% | 10,130.94 | 0% | -10.41% |
|
ASX:SHL
Sonic Healthcare
|
26.60 | 6.42% | 29.07% | 12,778.75 | 3.92% | 5.68% |
|
SWX:BANB
Bachem Holding
|
81.25 | -3.91% | 18.49% | 6,091.61 | 0.98% | -15.25% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
657.50 | 0% | 0% | 40,945.73 | 0% | 0% |
|
HLSE:ORNBV
Orion Oyj
|
36.40 | 22.61% | 65.62% | 5,117.58 | 4.45% | -0.43% |
